Metabolic Dysfunction-associated Steatohepatitis

• CLINICAL_TRIALS trial_result · 2026-04-16
  Clinical Trial Update: LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis [Phase 3]

  Phase 3 clinical trial evaluating survodutide for metabolic dysfunction-associated steatohepatitis (NASH) with cirrhosis is currently recrui…

• CLINICAL_TRIALS trial_result · 2026-04-03
  Clinical Trial Update: A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH [Phase 2]

  A Phase 2 study evaluating the tolerability of BI 770371 in people with compensated cirrhosis due to MASH has completed.

• CLINICAL_TRIALS trial_result · 2025-08-28
  Clinical Trial Update: Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults [NA]

  This clinical trial update indicates that a behavioral lifestyle intervention for Metabolic dysfunction-associated steatotic liver disease (…

• CLINICAL_TRIALS trial_result · 2025-08-13
  Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects [Phase 1]

  Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of CS060380 in healthy and elevated LDL-C subjects; the listed condi…

• CLINICAL_TRIALS trial_result · 2025-06-03
  Clinical Trial Update: Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM [NA]

  A completed clinical trial evaluating the efficacy and safety of CS0159 in combination with semaglutide for patients with Metabolic Dysfunct…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-02-17
  Clinical Trial Update: ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) [Phase 2]

  Phase 2 trial update: ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis/nonalcoholic steatohepatitis …

• CLINICAL_TRIALS trial_result · 2025-02-07
  Clinical Trial Update: Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

  A clinical trial evaluating prognostic factors for hepatocellular carcinoma and liver transplantation in patients with MASLD/MASH; recruitme…

• CLINICAL_TRIALS trial_result · 2024-12-19
  Clinical Trial Update: Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]

  Phase 2 study of TVB-2640 in MASLD/MASH/NASH has completed with results posted.